Swiatek tested positive for trimetazidine shortly after her Cincinnati Open campaign in August and has been stripped of her prize money from that event. Amid the latest doping saga to take tennis ...

Objective: To assess the clinical efficacy, safety and effects on quality of life of trimetazidine modified release (MR) in patients with stable angina. Methods: This large, open-label ...

Trimetazidine, known as TMZ, is a drug used to treat angina and other heart-related conditions. It works by increasing blood flow to the heart and limiting rapid swings in blood pressure. The drug is ...

The World Anti-Doping Agency said on Friday it has dropped its lawsuit against the U.S. Anti-Doping Agency in a dispute ...

The World Anti-Doping Agency withdrew this week the defamation lawsuit it filed against the United States Anti-Doping Agency ...

Iga Swiatek heaved a sigh of relief after the International Tennis Integrity Agency (ITIA) declared that she bore no fault or negligence after contamination by trimetazidine. Along with the ban, she ...

This large open-label study was conducted by cardiologists, in ten regions of Russia, in patients with stable angina diagnosed at least 6 months previously and with an average of more than three ...